SEC Form 4 · accession 0000905718-19-000095
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edmund Cannon
Director
Period of report
Jan 31, 2019
Accepted (ET)
Feb 1, 2019 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Jan 31, 2019 | P | 43,479 | $0.23 | A | 61,873 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24: Power of Attorney